Who
Theodora Mistras
CVP, Chief Financial Officer
Company insider
Files Form 4 as: CVP, Chief Financial Officer, Edwards Lifesciences; Chief Financial Officer, Viatris.
In numbers
- Trades disclosed
- 60
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 4 Mar 2024
- Last trade
- 9 Jul 2026
- Last filed
- 10 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jul 2026filed 10 Jul 2026 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —87,595 at $0.00 | filing |
| 9 Jul 2026filed 10 Jul 2026 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —12,325 at $0.00 | filing |
| 9 Jul 2026filed 10 Jul 2026 | EW Edwards Lifesciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —61,800 at $0.00 | filing |
| 9 Jul 2026filed 10 Jul 2026 | EW Edwards Lifesciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —61,800 at $0.00 | filing |
| 9 Jul 2026filed 10 Jul 2026 | EW Edwards Lifesciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —12,325 at $0.00 | filing |
| 9 Jul 2026filed 10 Jul 2026 | EW Edwards Lifesciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —12,325 at $0.00 | filing |
| 9 Jul 2026filed 10 Jul 2026 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —87,595 at $0.00 | filing |
| 9 Jul 2026filed 10 Jul 2026 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —12,325 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS ViatrisPharmaceuticals | SEC FORM 4 Code M | —41,711 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS ViatrisPharmaceuticals | SEC FORM 4 Code F | $327K23,067 at $14.16 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS ViatrisPharmaceuticals | SEC FORM 4 Code M | —2,071 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —41,711 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,070.6 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —86,017 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS ViatrisPharmaceuticals | SEC FORM 4 Code F | $16K1,146 at $14.16 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —41,711 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,070.604 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —86,017 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS ViatrisPharmaceuticals | SEC FORM 4 Code M | —41,711 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS ViatrisPharmaceuticals | SEC FORM 4 Code F | $327K23,067 at $14.16 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.